Hydroxyrubicin, a deaminated derivative of doxorubicin, inhibits mammalian DNA topoisomerase II and partially circumvents multidrug resistance

Eric Solary, Vi‐He ‐H Ling, Roman Perez‐Soler, Waldemar Priebe, Yves Pommier

Research output: Contribution to journal › Article › peer-review

18 Scopus citations

Fingerprint

Dive into the research topics of 'Hydroxyrubicin, a deaminated derivative of doxorubicin, inhibits mammalian DNA topoisomerase II and partially circumvents multidrug resistance'. Together they form a unique fingerprint.

Medicine & Life Sciences